Viewing
|Articles|May 1, 2007

Practice management in the era of anti-VEGF therapy (Part I)

Identifying the bottlenecks that are preventing effective management of neovascular AMD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME